Nexium Switch Bid Drops As PPI Market Slumps
This article was originally published in The Tan Sheet
Executive Summary
AstraZeneca says it has filed an application to switch the heartburn drug Nexium, which would be marketed OTC by Pfizer. The category has been flat in recent sales periods, with P&G’s Prilosec OTC losing ground to private label.